tsamba_banner

nkhani

Msika Wapadziko Lonse wa Mankhwala Ochepa a Peptide mpaka 2040: Kukwera Ndalama Zapagulu ndi Payekha kuti Zithandizire Kukula

DUBLIN, June 26, 2023- Lipoti "Msika Woletsedwa wa Peptide Drug - Kusanthula Kwapadziko Lonse ndi Zachigawo: Yang'anani pa Mitundu ya Peptide, Zogulitsa ndi Kusanthula Kwachigawo - Analysis and Forecast, 2024-2040".
Kukhazikitsidwa koyambirira kwa msika wamankhwala oyamba oletsa ma peptide, msika wamankhwala woletsedwa padziko lonse lapansi ukuyembekezeka kukula kuchokera ku 2024 mpaka 2040. Msika ukuyembekezeka kufika $60M mu 2024 ndi $17.38B mu 2040, ndi CAGR ya 38.94% kuposa nthawi yolosera 2025-2040.
Msika wapadziko lonse wamankhwala oletsa ma peptide akuyembekezeka kukula kwambiri panthawi yolosera kuyambira 2025 mpaka 2040, motsogozedwa kwambiri ndi lonjezo la payipi yatsopano yoletsa ya peptide yomwe siilinso ndi zomwe amalandila.Kupita patsogolo kwaukadaulo wamakina, kupita patsogolo kwamalonda azachipatala opangira ma peptide m'zaka zaposachedwa, komanso mitengo yotsika mtengo yomwe ma biomolecules awa amadwala matenda osiyanasiyana ndi zina mwazinthu zowonjezera zomwe zikuthandizira kukula komwe kukuyembekezeka panthawi yanenedweratu.
Kuwunika kwa zotsatira za nthawi yochepa komanso yanthawi yayitali kumachitika pazifukwa zomwe zimakhudza kwambiri msika, zomwe ndi madalaivala, zopinga ndi mwayi.Kuwunika kwakanthawi kochepa kumaganizira nthawi ya 2020-2025 ndipo kuwunika kwanthawi yayitali kumaganizira nthawi ya 2026-2040.
Zotukuka zazikulu ndi njira zomwe ena mwa omwe akuchita nawo msikawu zaphatikizidwa pakuwunika kwazomwe zikuchitika.Kuphatikiza apo, zochitika zazikuluzikuluzi zimawunikidwa kuti amvetsetse mwayi wamtsogolo wophatikiza matekinoloje apamwamba kuti akwaniritse zotsatira zapamwamba.Kuphatikiza apo, kuvomereza ndi kukhazikitsidwa kwamakampani ndi mabungwe omwe ali ndi patent amaganiziridwanso pakuwunika momwe msika wapadziko lonse wamankhwala amapeptide oletsa ma peptide.
Zofunikira ndi Zolepheretsa Zotsatirazi ndizomwe zikufunidwa pamsika wapadziko lonse wa Peptide Dependence Inhibitors:
4 Chidule cha Msika 4.1 Chiyambi 4.1.1 Mapangidwe ndi Mapangidwe a Peptides Oletsedwa 4.1.2 Mitundu ya Peptides Oletsedwa 4.2 Kusintha kwa Peptides Oletsedwa 4.3 Kupanga Ma Peptides Oletsedwa Monga Mankhwala 4.4 Zomwe Zingatheke Zochizira 4.5 Magawo Ofunika Kwambiri 6 Magawo Ofunika Kwambiri ) ) 4.7 Zomwe zikuchitika m'makampani oyambira 4.8 Mfundo zazikuluzikulu zamakampani - kupita patsogolo kwaukadaulo 4.9 Kukula kwa msika ndi kuthekera kwakukula kwa msika, USD biliyoni, 2024-2040 ndi kukonzanso kwamakampani omwe amapanga mankhwala a peptide osagwiritsidwa ntchito mopanda malire.
5 Katundu wa ma peptides oletsedwa 5.1 Katundu wa ma peptides oletsedwa 5.2 Kaphatikizidwe ka ma peptides oletsedwa 5.2.1 Chemical ligation of peptides and bridging 5.2.2 Chemical ligation of peptides to scaffolds (CLIPS) 5.2.3 Plaptide Crosslinking of pe.2. kupezeka (5.2.5 Liquid-Phase Peptide Synthesis (LPPS) 5.2.6 Solid-Phase Peptide Synthesis (SPPS) 5.3 Advances in Peptide Technology 5.3.1 Peptide Synthesis Pogwiritsa Ntchito Microfluidics 5.3.2 Solid-Phase Peptide Synthesis (SPPS) Sankhani System
6 Deta ya Makampani 6.1 Mwachidule 6.2 Nkhani Zovomerezeka Zovomerezeka Njira Zoletsa Peptides 6.3 Zoyang'anira Zokhudza Peptides Oletsedwa 6.4 Zofunikira ndi Kapangidwe ka US 6.4.1 Chilolezo Chachipatala 6.4.2 Chilolezo Chakuyesa Kwachipatala 6.4.2 Chilolezo Chogulitsa 3 ulamuliro 6.5 European malamulo malamulo ndi chimango 6.5.1 EMA chilolezo ntchito ndondomeko 6.5.2 Centralized ndondomeko 6.5.3 Decentralized ndondomeko 6.5.4 ndondomeko kuzindikira mgwirizano 6.5.5 National ndondomeko 6.6 Zofunika zamalamulo ndi frameworks mu Asia -Pacific dera 6.6.1 Zofunikira pazamalamulo ndi kapangidwe kake ku Japan 6.7 Kubweza 6.7.1 Kubweza matenda odziyimira pawokha 6.7.2 Kubwezeranso kwa khansa
7 Mphamvu Zamsika 7.1 Kuwunika Zokhudza Msika 7.2 Zinthu Zamsika 7.2.1 Kuchulukitsa Kugwirizana Kwamabizinesi ndi Kugwiritsa Ntchito Ma Cellular 7.2.2 Kupanga Njira Zochepa Zopangira 7.2.3 Zochepa za Peptides Okhazikika 7.2.4 Kuwonjezeka kwa Ndalama Zapagulu ndi Zachinsinsi. .4 .2 Ndalama zoperekedwa ndi makampani otchulidwa 7.2.4.3 Ndalama zoperekedwa ndi mabungwe aboma 7.3 Zolepheretsa msika 7.3.1 Kuchulukitsa mpikisano wa biologics 7.3.2 Kuopsa kwa chitetezo chamthupi ndi katundu wocheperako wa ADME 7.4 Mwayi wamsika 7.4.1 Ma peptides ochepa pakupeza mankhwala 7.4.2 Zosiyanasiyana ntchito mantha dongosolo ndi khansa mankhwala
8 Mpikisano wa malo 8.1 Kufotokozera mwachidule za malo opikisana
9 Msika wapadziko lonse woletsa mankhwala a peptide (mwa mayendedwe), mln USD, 2024-2040 9.1 Kapangidwe ka Clinical Trial Design for Restraining Peptide Therapies 9.1.1 Potential Phase II Therapies II) 9.1.2.3 Efficacy, Safety, and Tolerability Data (Gawo 1) 9. .2.4 Nonclinical Studies of BT5528 9.1.3 PN-9439.1.3.1 Product Introduction 9.1.3.2 Maphunziro a mapangidwe (Gawo 2) 9.1.3.3 Zambiri, chitetezo ndi kulekerera deta (Phase II) 9.1.4 PN-2319.1.4. 4.2 Mapangidwe a Phunziro (Gawo IIb) 9.1.4.3 Zambiri, chitetezo ndi kulolera (Phase IIb) 9.1.5 Rusfertide (PTG-300) 9.1.5.1 Zogulitsa 9.1.5.2 Mapangidwe a Phunziro (Gawo II) 9.1.5.3 Kuchita bwino, chitetezo ndi chitetezo Deta yolekerera (Gawo IIa) 9.1.6 Mankhwala Otheka a Gawo III 9.1.7 Zilukoplan (RA101495) 9.1.7.1 Zogulitsa 9.1.7.2 Kapangidwe ka phunziro (Gawo III) 9.1.7.3 Zambiri, chitetezo ndi kulekerera deta (Gawo III.7.7.49). Pharmacokinetic ndi pharmacodynamic mbiri ya Zilucoplan (Phase I) 9.1.8 Rusfertide (PTG- 300) 9.1.8.1 Zotsatira za mankhwala 9.1.8.2 Kapangidwe ka phunziro (Phase III) 9.1.8.3 Zambiri, chitetezo ndi kulekerera deta (Phase II) 9.2 Kukula kwa msika wapadziko lonse wamankhwala oletsa ma peptide, USD miliyoni, kupambana kwa 2024-2040 9.2.2.2 Mtengo Wopanga API (CDMO)
10 Msika wapadziko lonse wa mankhwala okhala ndi ma peptide ochepa (mwa mtundu wa peptide), US $ mln, 2024-2040 peptide yolumikizidwa (DRP))
11 Msika wapadziko lonse wamankhwala oletsedwa a peptide (ndi zinthu zomwe zingatheke), mln USD, 2024-2040 (RA101495) 11.1.2.1 kupanga API (zapakhomo) 11.1.2.2 API yofunikira ya 2024-2040 11.1.3 Rusfertide-101 (Rusfertide) .3.1 API Production (Outsourcing) Mtengo 11.1.4 PN-94311.1.4.1 API Production (Outsourcing) 11.1.4.2 API Demand Forecast 2024-2040


Nthawi yotumiza: Jul-06-2023